Novo Nordisk has released blockbuster fat-reduction drug Wegovy in Germany, its first massive European marketplace, hoping Germans will pay many euros outside of pocket for the drug that community health and fitness insurance policy strategies are thus far barred from covering.In Germany, the term “bio” is much more than simply a label; it’s